Senior Software Engineer in Test

Validfor vs Veeva Vault QMS: which QMS platform is better in 2026? Last updated: April 10, 2026 9:46 am Quality Management Systems (QMS) are essential for organizations in regulated industries such as pharmaceuticals, biotechnology, and medical devices. Choosing the right platform affects compliance, operational efficiency, and long-term scalability. In this comparison, Compliance in Pharma explore Validfor and Veeva Vault QMS to help you determine which solution best fits your needs. Overview of Validfor. Validfor is a modern validation-focused platform built with an automation-first approach. It focuses on continuous compliance, workflow automation, and reducing manual validation effort. Validfor is ideal for organizations seeking speed, flexibility, and efficiency. Overview of Veeva Vault QMS. Veeva Vault QMS is a cloud-based QMS platform designed specifically for life sciences. It provides comprehensive quality management capabilities, including document control, training, CAPA, and audit management. Veeva Vault QMS is widely used by global pharmaceutical and biotech companies. Key differences. 1. Platform focus. Validfor is primarily focused on validation automation and continuous compliance. Veeva Vault QMS is a full QMS platform covering all quality processes. 2. Automation. Validfor is built with automation at its core, enabling real-time validation and reduced manual effort. Veeva Vault QMS offers automation across quality processes but follows a more structured QMS framework. 3. Ease of use. Validfor provides a modern, user-friendly interface designed for fast adoption. Veeva Vault QMS has a robust interface but may require training due to its extensive features. 4. Implementation speed. Validfor is designed for rapid deployment and quick onboarding. Veeva Vault QMS implementations can take longer, especially in large enterprises. 5. Scalability. Both platforms are highly scalable. Validfor is well-suited for agile teams, while Veeva Vault QMS is optimized for large global organizations. 6. Compliance. Both platforms support GxP and regulatory compliance. Veeva Vault QMS has a strong track record in life sciences, while Validfor emphasizes continuous compliance through automation. Pros and cons. Validfor. * Automation-first approach * Fast implementation * Modern and intuitive interface * Continuous compliance capabilities * Limited full QMS functionality Veeva Vault QMS. * Comprehensive QMS features * Strong life sciences specialization * Global scalability * Longer implementation time * More complex setup and usage Which one should you choose? The best choice depends on your organization's scope and priorities. * Choose Validfor if: You want automation, speed, and validation-focused workflows * Choose Veeva Vault QMS if: You need a full QMS platform for enterprise-scale operations Final thoughts. Validfor and Veeva Vault QMS serve different roles within regulated environments. Veeva Vault QMS provides a comprehensive, enterprise-grade QMS solution, while Validfor represents a modern, automation-driven approach to validation. By aligning your choice with your operational needs, you can achieve better compliance, efficiency, and scalability. In recent years, validation processes across the pharmaceutical industry have been undergoing a major transformation. Workflows that were traditionally managed through paper documentation, spreadsheets and manual review cycles are increasingly moving toward digital validation platforms. As a result, life sciences organizations often evaluate solutions such as Kneat, Validfor, ValGenesis, MasterControl and Veeva when modernizing validation lifecycle management and compliance documentation. News & research. Audit management is a vital process in regulated industries such as pharmaceuticals, biotechnology, and medical devices. Organizations must plan, execute,... April 10, 2026 Validfor is rapidly emerging as a next-generation digital validation platform, designed to address the evolving needs of modern pharmaceutical and... April 10, 2026 Inspection readiness is about retrieval speed During an inspection, the biggest risk is not the absence of controls. It is... April 9, 2026 In highly regulated industries, validation and quality management systems play a critical role in ensuring compliance, product quality, and operational... April 9, 2026

Missouri Southern to host Global Leaders Speaker Series, featuring Dr. Monicca Shanthanelson. Missouri Southern State University (MSSU) will host the Global Leaders Speaker Series on Monday, April 13, in the Ron Richard Athletic Center from 6 p.m. to 8 p.m. The event is free and open to the public. The series aims to inspire and inform attendees interested in scientific innovation and global leadership to build a more connected world. 0This event will feature a keynote address by Dr. Monicca Shanthanelson, a global Medical Affairs executive with more than 15 years of experience in enterprise medical strategy, scientific communications, and organizational leadership across oncology and neuroscience. She holds a PhD in Neuroscience from Stony Brook University and earned dual undergraduate degrees in Biology and Chemistry from Missouri Southern State University. "Giving our students the opportunity to hear from experts in a diverse set of fields lets them learn leadership and global citizenship skills from people who have lived experience in both of those areas," said Benjamin Cooper, MSSU's Director of Global Leaders. "Bringing Dr. Shanthanelson back to the MSSU campus is an exciting opportunity for them to learn from someone who was once in their position and has gone on to have global reach in her career." She currently serves as Scientific Director of Cross-Oncology Strategy within Global Medical Affairs at AbbVie, where she leads initiatives that align medical teams across international markets. In her many impressive roles, Dr. Shanthanelson has developed global frameworks to expand the reach of clinical data and improve coordination across major groups. Her work has contributed to measurable operational efficiencies and the adoption of standardized practices across global oncology teams, making a true impact. Prior to joining AbbVie, Dr. Shanthanelson served as Vice President and Global Head of Medical Affairs Business Consulting at Veeva Systems. There, she advised life sciences organizations and executive Medical Affairs leaders on global strategy, omnichannel engagement transformation, insight generation, and digital enablement of scientific exchange while owning profitability and client satisfaction. She also held senior leadership roles at MedThink SciCom (now FingerPaint Medical) where she supported pharmaceutical clients worldwide. With her impressive array of accomplishments, attendees of the Global Leaders Speaker Series are guaranteed to walk away with fresh insight from Dr. Shanthanelson. About Global Leaders Speaker Series Missouri Southern's Global Leaders Speaker Series reflects the university's ongoing commitment to fostering global perspectives and connecting students and the community with leaders and visionaries shaping the future of their industries. Through events like this, the university continues to create spaces and opportunities for meaningful dialogue, propagating students' learning and engagement beyond the classroom. For more information about the Global Leaders program, visit the program webpage.